Article citationsMore>>

N. P. Shah, H. M. Kantarjian, D. W. Kimatinib, D. Réa, P. E. Dorlhiac-Llacer, J. H. Milone, J. Vela-Ojeda, R. T. Silver, H. J. Khoury, A. Charbonnier, N. Khoroshko, R. L. Paquette, M. Deininger, R. H. Collins, I. Otero, T. Hughes, E. Bleickardt, L. Strauss, S. Francis and A. Hochhaus, “Intermittent Target Inhibition with Dasatinib 100 mg Once Daily Reserves Efficacy and Imatinib Proves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia,” Journal of Clinical Oncology, Vol. 26, No. 19, 2008, pp. 3204-3212. doi:10.1200/JCO.2007.14.9260

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top